CLINICAL_TRIALS
withdrawal
· 2022-07-08
Clinical Trial Update: Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention [Phase 4]
Summary
Phase 4 trial of methenamine for non-antibiotic, multimodal UTI prevention has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: UTI, Female Urogenital Diseases | Phase 4 | Status: WITHDRAWN